Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,930 shares at $699.00 ($1.3M) on 2022-03-30, disclosed to the SEC on 2022-03-31.
Seasonal sale ($1.3M) by Director — this insider has traded REGN in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $699.00 | 1,522 | $1.1M | 78.9% |
| 2 | $699.00 | 408 | $285K | 21.1% |
| Total | $699.00 avg | 1,930 | $1.3M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |